Welcome to our dedicated page for Phreesia SEC filings (Ticker: PHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Phreesia's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Phreesia's regulatory disclosures and financial reporting.
Phreesia, Inc. (PHR) has filed a Form 144 indicating that shareholder Yvonne Hui intends to sell 307 common shares, worth about $8,371.83, through Fidelity Brokerage on or about 15 July 2025. With 59,504,269 shares outstanding, the planned sale represents roughly 0.0005% of the company’s float.
The filing also discloses that the same seller disposed of 4,208 shares over the past three months in six separate transactions, generating gross proceeds of approximately $104,610. The 307 shares being registered for sale were acquired on 11 July 2025 via restricted-stock vesting and constitute compensation-related stock.
The notice includes the standard certification that the seller is unaware of any non-public adverse information about Phreesia. Given the very small size relative to total shares outstanding and the routine nature of Rule 144 sales, this event is unlikely to be materially impactful for investors.
On July 2, 2025, Phreesia, Inc. (PHR) director Mark Douglas Smith filed a Form 4 disclosing an option exercise and immediate share sale under a pre-arranged Rule 10b5-1 plan.
- Option exercise (Code M): 7,000 shares converted at an exercise price of $4.71.
- Open-market sale (Code S): the same 7,000 shares sold at $29.00 per share, generating roughly $203k gross proceeds.
- After the transactions, Smith’s direct ownership declined from 44,353 to 37,353 common shares.
- The underlying stock option was fully vested and would have expired on September 4, 2028; no derivative holdings remain related to this grant (51,193 total derivative securities now held).
The activity represents a 15.8 % reduction in Smith’s directly held shares. Because the sale was executed pursuant to a 10b5-1 plan adopted on January 10, 2025, market-timing concerns are mitigated, although investors may still view insider net selling as a modest negative signal.